InformatikEnglischGhost

Front Matter

Front Matter
The Front Matter Blog covers the intersection of science and technology since 2007.
StartseiteAtom-FeedMastodonISSN 2749-9952
language
NewsInformatikEnglisch
Veröffentlicht

Two weeks ago Eva Amsen wrote in a thoughtful blog post: There’s a gap between science and technology, and it’s growing. Eva argues that – contrary to popular belief – there is actually a divide between science and technology. Scientists are on average not really comfortable using technology, and many computing tools aimed for scientists really miss the point of what scientists really care about.

NewsInformatikEnglisch
Veröffentlicht

Last Friday the latest science blogging network officially launched: Occam’s Typewriter. The independent blogging network started out with eight bloggers and one guest blog, all of them well characterized by Bob O’Hara. Most of the bloggers have moved their blogs from Nature Network, where I wrote next to them from 2007 until September this year.

FeatureInformatikEnglisch
Veröffentlicht

In early December Knowledge Exchange, a partnership of JISC (United Kingdom), SURF (Netherlands), DEFF (Denmark), and DFG (Germany) released a report on submission fees that they had commissioned to Mark Ware Consulting. The report was also discussed by Robert Kiley on the UK PubMed Central blog and by Phil Davis on the Scholarly Kitchen blog. Submission fees are more common than I thought, particularly in economics and the life sciences.

Meeting ReportInformatikEnglisch
Veröffentlicht

Four weeks ago I wrote about the Beyond the PDF workshop that is planned for January in San Diego. The goal of the workshop is to identify a set of requirements, and a group of willing participants to develop open source code to accelerate scientific knowledge sharing. The Google Group for the workshop has already seen a lot of interesting discussions.

FeatureInformatikEnglisch
Veröffentlicht

On Monday I was finally able to start the clinical trial Everolimus for patients with relapsed/refractory germ cell cancer (RADIT), and I’m now looking forward to recruit the first patient. We aim to treat 25 patients with cancer of the testis with the mTOR inhibitor everolimus in this phase II trial, and eight German hospitals are participating.

FeatureInformatikEnglisch
Veröffentlicht

Last Tuesday Nucleic Acids Research published a nice paper describing the UK PubMed Central (UKPMC) database (McEntyre 2010). UKPMC was started in 2007, the enhanced version described in the paper was launched January 2010. In November 2009 I published an interview with Phil Vaughan, the senior author of the paper.